デフォルト表紙
市場調査レポート
商品コード
1624439

安定同位体標識化合物の世界市場規模:タイプ別、最終用途別、地域別、範囲および予測

Global Stable Isotope Labeled Compounds Market Size By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15), By End-Use (Research Institutes, Pharmaceutical & Biopharmaceutical), By Geographic Scope And Forecast


出版日
ページ情報
英文 202 Pages
納期
2~3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
安定同位体標識化合物の世界市場規模:タイプ別、最終用途別、地域別、範囲および予測
出版日: 2024年09月27日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

安定同位体標識化合物の市場規模と予測

安定同位体標識化合物の市場規模は、2021年に2億7,823万米ドルと評価され、2023年から2030年にかけてCAGR 3.64%で成長し、2030年には3億8,351万米ドルに達すると予測されています。この市場の成長は、製薬・バイオテクノロジー分野での研究活動の増加などが主な要因となっています。また、がんの罹患率が上昇していることも、安定同位体標識化合物を用いた調査活動を活発化させています。この調査レポートは、安定同位体標識化合物の世界市場を総合的に評価しています。主要セグメント、動向、市場促進要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の安定同位体標識化合物市場の定義

安定同位体標識には、様々な化学・生化学システムのモデル化に使用されるトレーサーとして機能する非放射性同位体の使用が含まれます。同位体は、核磁気共鳴(NMR)や質量分析(MS)を通して、化合物の識別可能な標識として機能します。一般的に使用される安定同位体には、2H、13C、15Nがあります。安定同位体標識化合物は、代謝を介した毒性研究に従事する研究者の間で大きな関心を呼んでいます。その役割は、膨大な代謝研究におけるin vivo代謝の評価において、無視できないほど高まっています。メタボロミクス研究以外にも、安定同位体標識化合物は環境分析、プロテオミクス、医療診断研究においてますます使用されるようになってきています。

安定同位体標識化合物の世界市場概要

本レポートの市場展望のセクションは、主に本質的な市場力学、市場促進要因・課題、市場抑制要因、機会を網羅しています。市場促進要因・抑制要因は内在的要因であり、市場促進要因・課題は外在的要因です。

この市場の成長は、製薬およびバイオテクノロジー部門における分析活動の増加などの要因によって大きく左右されます。また、がんの有病率が上昇していることも、安定同位体標識化合物を用いた分析活動に拍車をかけています。さらに、安定同位体標識化合物市場は、オーダーメイド医療や医薬品の分野での分析活動の活発化により、一定期間ごとに増加しており、安定同位体標識化合物市場が予測期間中に健全に成長する絶好のチャンスとなっています。しかし、安定同位体標識化合物の導入には高額な設備投資が必要であり、これがプラグ成長の最も重大な障壁となっています。

検証分析では、一次情報のデータ活用を絞り込んで知識を検証し、本格的な分析研究の集約に活用しています。本レポートは、消費者が関心を持つ市場部分の定量的・定性的な推定を含んでいます。世界の安定同位体標識化合物市場」はサブセグメントに分割されており、最新の動向に関する分類された知識を間隔をおいて提供することができます。

目次

第1章 安定同位体標識化合物の世界市場イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 安定同位体標識化合物の世界市場展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析

第5章 安定同位体標識化合物の世界市場:タイプ別

  • 概要
  • 炭素-13
  • 窒素-15
  • 重水素
  • 酸素-18

第6章 安定同位体標識化合物の世界市場:最終用途別

  • 概要
  • 研究機関
  • 製薬・バイオ医薬品
  • その他

第7章 安定同位体標識化合物の世界市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第8章 安定同位体標識化合物の世界市場:競合情勢

  • 概要
  • 各社の市場ランキング
  • 主な開発戦略

第9章 企業プロファイル

  • Merck KGaA
  • Cambridge Isotope Laboratories, Inc.
  • PerkinElmer Inc.
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • Taiyo Nippon Sanso Corporation
  • Isosciences
  • Trace Sciences International
  • Alsachim
  • Urenco Stable Isotopes

第10章 主な発展

  • 製品上市/開発
  • 合併と買収
  • 事業拡大
  • パートナーシップと提携

第11章 付録

  • 関連調査
図表

LIST OF TABLES

  • TABLE 1 PRICING ANALYSIS
  • TABLE 2 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 3 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • TABLE 5 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 6 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 7 NORTH AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 8 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 9 U.S. STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 10 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 11 CANADA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 12 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 13 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 14 EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 15 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 16 GERMANY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 17 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 18 ITALY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 19 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 20 BENELUX STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 21 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 22 UK STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 23 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 24 RUSSIA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 25 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 26 SPAIN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 27 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 28 FRANCE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 29 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 30 REST OF EUROPE STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 31 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 32 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 33 ASIA PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 34 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 35 CHINA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 36 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 37 JAPAN STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 38 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 39 SOUTH KOREA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 40 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 41 REST OF ASIA-PACIFIC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 45 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 46 GCC STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 47 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 48 TURKEY STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 49 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 50 SOUTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 51 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 52 NORTH AFRICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 53 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY COUNTRY, 2018 - 2027 (USD MILLION)
  • TABLE 54 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 55 LATIN AMERICA STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 56 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 57 BRAZIL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 58 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE, 2018 - 2027 (USD MILLION)
  • TABLE 59 MEXICO STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE, 2018 - 2027 (USD MILLION)
  • TABLE 60 MERCK KGAA: PRODUCT BENCHMARKING
  • TABLE 61 CAMBRIDGE ISOTOPE LABORATORIES, INC.: PRODUCT BENCHMARKING
  • TABLE 62 PERKINELMER INC.: PRODUCT BENCHMARKING
  • TABLE 63 MEDICAL ISOTOPES, INC.: PRODUCT BENCHMARKING
  • TABLE 64 OMICRON BIOCHEMICALS, INC.: PRODUCT BENCHMARKING
  • TABLE 65 TAIYO NIPPON SANSO CORPORATION: PRODUCT BENCHMARKING
  • TABLE 66 ISOSCIENCES: PRODUCT BENCHMARKING
  • TABLE 67 TRACE SCIENCES INTERNATIONAL: PRODUCT BENCHMARKING
  • TABLE 68 ALSACHIM: PRODUCT BENCHMARKING
  • TABLE 69 URENCO STABLE ISOTOPES: PRODUCT BENCHMARKING

LIST OF FIGURES

  • FIGURE 1 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OVERVIEW
  • FIGURE 7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET GEOGRAPHICAL ANALYSIS, 2020- 2027
  • FIGURE 8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY PRODUCT TYPE, (USD MILLION)
  • FIGURE 9 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY APPLICATION (USD MILLION)
  • FIGURE 10 FUTURE MARKET OPPORTUNITIES
  • FIGURE 11 NORTH AMERICA DOMINATED THE MARKET IN 2019
  • FIGURE 12 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK
  • FIGURE 13 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE
  • FIGURE 14 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE
  • FIGURE 15 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY, 2018 - 2027 (USD MILLION)
  • FIGURE 16 NORTH AMERICA MARKET SNAPSHOT
  • FIGURE 17 EUROPE MARKET SNAPSHOT
  • FIGURE 18 ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE 19 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • FIGURE 20 LATIN AMERICA MARKET SNAPSHOT
  • FIGURE 21 MERCK KGAA: COMPANY INSIGHT
  • FIGURE 22 MERCK KGAA: SEGMENT BREAKDOWN
  • FIGURE 23 MERCK KGAA: SWOT ANALYSIS
  • FIGURE 24 CAMBRIDGE ISOTOPE LABORATORIES, INC.: COMPANY INSIGHT
  • FIGURE 25 CAMBRIDGE ISOTOPE LABORATORIES, INC.: SWOT ANALYSIS
  • FIGURE 26 PERKINELMER INC.: COMPANY INSIGHT
  • FIGURE 27 PERKINELMER INC.: SEGMENT BREAKDOWN
  • FIGURE 28 PERKINELMER INC.: SWOT ANALYSIS
  • FIGURE 29 MEDICAL ISOTOPES, INC.: COMPANY INSIGHT
  • FIGURE 30 OMICRON BIOCHEMICALS, INC.: COMPANY INSIGHT
  • FIGURE 31 TAIYO NIPPON SANSO CORPORATION: COMPANY INSIGHT
  • FIGURE 32 TAIYO NIPPON SANSO CORPORATION: SEGMENT BREAKDOWN
  • FIGURE 33 ISOSCIENCES: COMPANY INSIGHT
  • FIGURE 34 TRACE SCIENCES INTERNATIONAL: COMPANY INSIGHT
  • FIGURE 35 ALSACHIM: COMPANY INSIGHT
  • FIGURE 36 URENCO STABLE ISOTOPES: COMPANY INSIGHT
目次
Product Code: 24354

Stable Isotope Labeled Compounds Market Size And Forecast

Stable Isotope Labeled Compounds Market size was valued at USD 278.23 Million in 2021 and is projected to reach USD 383.51 Million by 2030 , growing at a CAGR of 3.64% from 2023 to 2030. The growth of this market is majorly driven by factors such as the increase in research activities in the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled research activities using such stable isotope-labeled compounds. The Global Stable Isotope Labeled Compounds Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Stable Isotope Labeled Compounds Market Definition

Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers used to model different chemical and biochemical systems. The isotope can act as an identifiable label on that compound through nuclear magnetic resonance (NMR) and mass spectrometry (MS). The Commonly used stable isotopes include 2H, 13C, and 15N. Stable isotope-labeled compounds have generated considerable interest among researchers engaged in metabolism-mediated toxicity studies. Their role has risen to insignificance in the assessment of in vivo metabolism in a vast range of metabolic research. Apart from metabolomics studies, stable isotope-labeled compounds are being increasingly used in environmental analysis, proteomics, and medical diagnostic research.

Global Stable Isotope Labeled Compounds Market Overview

The report's market outlook section primarily encompasses essential market dynamics, drivers, restraints, opportunities, and challenges the trade faces. Drivers and restraints are intrinsic factors, whereas opportunities and challenges are extrinsic factors of the market.

The growth of this market is majorly driven by factors like the rise in analysis activities within the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled analysis activities using such stable isotope-labeled compounds. Moreover, the increase at intervals in the Stable Isotope Labeled Compounds Market due to the rise in analysis activity, significantly at intervals in the area of customized medicine and medicines, presents a superb chance for the Stable Isotope Labeled Compounds Market to grow healthy over the forecast amount. However, implementing stable isotope-labeled compounds needs high capital investments, which is the most critical barrier to plug growth.

Verified analysis narrows down their data exploitation of primary sources to validate the knowledge and use it in the aggregation of a full-fledged analysis study. The report contains a quantitative and qualitative estimation of market parts that interest the consumer. The "Global Stable Isotope Labeled Compounds Market" is split into sub-segments that can provide classified knowledge regarding the most recent trends at intervals.

Global Stable Isotope Labeled Compounds Market: Segmentation Analysis

The Global Stable Isotope Labeled Compounds Market is Segmented on the basis of Type, End-Use, and Geography.

Stable Isotope Labeled Compounds Market, By Type

  • Deuterium
  • Oxygen-18
  • Carbon-13
  • Nitrogen-15

Based on Type, the market is segmented into Deuterium, Oxygen-18, Carbon-13, and Nitrogen-15. Deuterium accounted for the largest market share in 2019 followed by Oxygen-18. Deuterium-labeled compounds have been utilized efficiently by toxicologists and drug metabolism scientists to gain an understanding of drug disposition and the potential performance of these compounds in the target organ toxicities.

Stable Isotope Labeled Compounds Market, By End-Use

  • Research Institutes
  • Pharmaceutical & Biopharmaceutical
  • Others

Based on End-Use, the market is segmented into Research Institutes, Pharmaceutical & Biopharmaceutical, and Others. Research Institutes accounted for the largest market share in 2019. Government research institutes, medical research institutes, and academic research institutes employ stable isotope-labeled compounds for performing metabolomics and proteomics research studies.

Stable Isotope Labeled Compounds Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Stable Isotope Labeled Compounds Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the major contributor to the Stable Isotope Labeled Compounds Market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas.

Key Players

  • The "Global Stable Isotope Labeled Compounds Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Merck KGaA, Cambridge Isotope Laboratories, Inc., PerkinElmer Inc., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Taiyo Nippon Sanso Corporation, Isosciences, Trace Sciences International, Alsachim, Urenco Stable Isotopes.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with their product benchmark and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In July 2021, Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, has launched the first commercially available 12C-enriched methane-grade gas for quantum applications.
  • In July 2021, Bruker has entered into a partnership with Massachusetts-based Cambridge Isotope Laboratories (CIL), formalizing a long-term relationship between the two companies and further extending Bruker's capabilities to deliver end-to-end service solutions to its installed customer base in nuclear magnetic resonance (NMR) spectroscopy under the LabScape(R) brand.
  • In June 2020, Creative Proteomics, the main provider in proteomics and metabolomics services, delivered a few proteomics services to scientists. The assistance ranges incorporate four: iTRAQ naming help, name-free quantitation service, SILAC mass spectrometry service, and TMT proteomics service.
  • In June 2020, Cambridge Isotope Laboratories, (CIL) the largest manufacture and global supplier of stable isotopes and stable isotope-labeled compounds, collaborated with Alsachim to provide antiviral drug standards to researchers and clinicians exclusively in the Americas. These products are available through CIL in convenient packaging sizes and are adept for use as internal standards in therapeutic monitoring and quantitative analysis.
  • In December 2020, Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently began a significant capacity optimization of one of the production cascades at the 13C separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade's 13C production by 10%.
  • Merger & Acquisitions
  • In April 2018, TAIYO NIPPON SANSO CORPORATION totally acquired SAIL advances Inc., where it's valuable in assembling and conveying stable isotope-marked amino acids that are material in biotechnology-related businesses and the medication industry.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Carbon-13
  • 5.3 Nitrogen-15
  • 5.4 Deuterium
  • 5.5 Oxygen-18

6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE

  • 6.1 Overview
  • 6.2 Research Institutes
  • 6.3 Pharmaceutical & Biopharmaceutical
  • 6.4 Others

7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Merck KGaA
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Cambridge Isotope Laboratories, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 PerkinElmer Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Medical Isotopes, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Omicron Biochemicals, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Taiyo Nippon Sanso Corporation
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Isosciences
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Trace Sciences International
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Alsachim
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Urenco Stable Isotopes
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research